By KIM BELLARD I’d love to be writing about something fun. Something that makes us think about things in a new way, or something exciting that will take us into the future. There are lots of such things happening, but there’s too many Orwellian actions happening that I can’t be silent about. Diversity, we’re told,…
Healthcare is a data-driven industry, but it’s held together by incompatible, siloed data systems. Providers and payers need the ability to exchange data and update directories in real time; otherwise, they cannot ensure patients will access the high-quality care they deserve. The post Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To appeared…
A more measured approach to noncompete clauses can be fair to physicians and provider organizations, and also serve patients better. Here are four elements for a policy on noncompetes that will work for healthcare. The post Forging a Noncompete Policy That Works for Healthcare appeared first on MedCity News.
The proportion of Americans without health insurance remained stable in 2023, the Census Bureau reported Tuesday, close to the record low the Biden administration achieved in 2022 through expansions of public programs, including the Affordable Care Act. About 8% of Americans were uninsured, a statistically insignificant increase of just 0.1 percentage point from a year…
The impact of private equity investments in healthcare under the new administration is multifaceted. While deregulation and business-friendly policies could stimulate investment and drive innovation, there are significant concerns about the potential negative effects on healthcare quality and access. The post Will A Second Trump Term be a Financing Boon for Healthcare? appeared first on…
This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.
AstraZeneca’s Datroway, an antibody drug conjugate (ADC), is now FDA approved for advanced cases of breast cancer that is HR positive and HER2 negative. Datroway targets TROP2, the same cancer protein addressed by Trodelvy, a Gilead Sciences ADC also approved for breast cancer. The post AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast…
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were…
Joel Keenan, M.D., owner of York Primary Care in Maine, describes new tools in his eClinicalWorks EHR that are saving him time
The serial entrepreneur and CEO of Transcarent has dismissed care navigation companies in the past. What led him to buy Accolade, the biggest — though struggling — name in navigation? The post Is Glen Tullman a Hypocrite or a Victim of the System He Aimed to Disrupt? appeared first on MedCity News.